25 XP   0   0   10

Tela Bio Inc
Buy, Hold or Sell?

Let's analyse Tela Bio Inc together

PenkeI guess you are interested in Tela Bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Tela Bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Tela Bio Inc

I send you an email if I find something interesting about Tela Bio Inc.

Quick analysis of Tela Bio Inc (30 sec.)










What can you expect buying and holding a share of Tela Bio Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
4.5%

What is your share worth?

Current worth
$0.77
Expected worth in 1 year
$0.95
How sure are you?
27.3%

+ What do you gain per year?

Total Gains per Share
$0.19
Return On Investment
3.9%

For what price can you sell your share?

Current Price per Share
$4.70
Expected price per share
$4.235 - $6.05
How sure are you?
50%

1. Valuation of Tela Bio Inc (5 min.)




Live pricePrice per Share (EOD)

$4.70

Intrinsic Value Per Share

$-19.49 - $-22.80

Total Value Per Share

$-18.72 - $-22.03

2. Growth of Tela Bio Inc (5 min.)




Is Tela Bio Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$18.8m$11.5m$11.6m50.2%

How much money is Tela Bio Inc making?

Current yearPrevious yearGrowGrow %
Making money-$12.1m-$11.7m-$435.5k-3.6%
Net Profit Margin-85.3%-115.9%--

How much money comes from the company's main activities?

3. Financial Health of Tela Bio Inc (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#215 / 340

Most Revenue
#173 / 340

Most Profit
#269 / 340

Most Efficient
#234 / 340

What can you expect buying and holding a share of Tela Bio Inc? (5 min.)

Welcome investor! Tela Bio Inc's management wants to use your money to grow the business. In return you get a share of Tela Bio Inc.

What can you expect buying and holding a share of Tela Bio Inc?

First you should know what it really means to hold a share of Tela Bio Inc. And how you can make/lose money.

Speculation

The Price per Share of Tela Bio Inc is $4.7. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tela Bio Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tela Bio Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.77. Based on the TTM, the Book Value Change Per Share is $0.05 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tela Bio Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.52-11.1%-0.47-10.1%-0.45-9.6%-0.37-7.9%-0.35-7.5%
Usd Book Value Change Per Share-0.47-10.1%0.051.0%-0.06-1.3%0.326.8%0.030.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.47-10.1%0.051.0%-0.06-1.2%0.326.8%0.040.7%
Usd Price Per Share6.62-8.85-9.67-9.84-8.95-
Price to Earnings Ratio-3.16--4.73--5.50--6.96--6.33-
Price-to-Total Gains Ratio-13.98--12.89--16.63--26.02--26.02-
Price to Book Ratio8.64-26.21--13.67-6.81-6.19-
Price-to-Total Gains Ratio-13.98--12.89--16.63--26.02--26.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.7
Number of shares212
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.050.32
Usd Total Gains Per Share0.050.32
Gains per Quarter (212 shares)9.8467.45
Gains per Year (212 shares)39.36269.80
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1039290270260
2079680539530
301181071809800
40157146110781070
50197185113481340
60236224116181610
70275263118871880
80315302121572150
90354341224272420
100394380226962690

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.022.00.00.0%0.022.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%6.014.00.030.0%6.016.00.027.3%6.016.00.027.3%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%1.00.021.04.5%1.00.021.04.5%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%6.014.00.030.0%6.016.00.027.3%6.016.00.027.3%

Fundamentals of Tela Bio Inc

About Tela Bio Inc

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Fundamental data was last updated by Penke on 2024-04-12 19:52:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Tela Bio Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Tela Bio Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Tela Bio Inc to the Medical Devices industry mean.
  • A Net Profit Margin of -75.8% means that $-0.76 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tela Bio Inc:

  • The MRQ is -75.8%. The company is making a huge loss. -2
  • The TTM is -85.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-75.8%TTM-85.3%+9.4%
TTM-85.3%YOY-115.9%+30.7%
TTM-85.3%5Y-125.2%+40.0%
5Y-125.2%10Y-133.4%+8.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-75.8%-11.2%-64.6%
TTM-85.3%-19.6%-65.7%
YOY-115.9%-14.4%-101.5%
5Y-125.2%-21.3%-103.9%
10Y-133.4%-24.8%-108.6%
1.1.2. Return on Assets

Shows how efficient Tela Bio Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tela Bio Inc to the Medical Devices industry mean.
  • -16.5% Return on Assets means that Tela Bio Inc generated $-0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tela Bio Inc:

  • The MRQ is -16.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -16.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.5%TTM-16.1%-0.4%
TTM-16.1%YOY-19.2%+3.1%
TTM-16.1%5Y-14.7%-1.3%
5Y-14.7%10Y-15.1%+0.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.5%-4.0%-12.5%
TTM-16.1%-4.5%-11.6%
YOY-19.2%-4.8%-14.4%
5Y-14.7%-4.0%-10.7%
10Y-15.1%-5.2%-9.9%
1.1.3. Return on Equity

Shows how efficient Tela Bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tela Bio Inc to the Medical Devices industry mean.
  • -68.3% Return on Equity means Tela Bio Inc generated $-0.68 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tela Bio Inc:

  • The MRQ is -68.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -144.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-68.3%TTM-144.6%+76.3%
TTM-144.6%YOY-59.5%-85.1%
TTM-144.6%5Y-51.1%-93.5%
5Y-51.1%10Y-46.5%-4.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-68.3%-3.9%-64.4%
TTM-144.6%-5.6%-139.0%
YOY-59.5%-5.9%-53.6%
5Y-51.1%-6.1%-45.0%
10Y-46.5%-7.1%-39.4%

1.2. Operating Efficiency of Tela Bio Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Tela Bio Inc is operating .

  • Measures how much profit Tela Bio Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tela Bio Inc to the Medical Devices industry mean.
  • An Operating Margin of -72.2% means the company generated $-0.72  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tela Bio Inc:

  • The MRQ is -72.2%. The company is operating very inefficient. -2
  • The TTM is -76.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-72.2%TTM-76.5%+4.2%
TTM-76.5%YOY-96.1%+19.6%
TTM-76.5%5Y-109.2%+32.8%
5Y-109.2%10Y-119.1%+9.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-72.2%-21.4%-50.8%
TTM-76.5%-18.0%-58.5%
YOY-96.1%-13.7%-82.4%
5Y-109.2%-19.2%-90.0%
10Y-119.1%-24.0%-95.1%
1.2.2. Operating Ratio

Measures how efficient Tela Bio Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.72 means that the operating costs are $1.72 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Tela Bio Inc:

  • The MRQ is 1.722. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.765. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.722TTM1.765-0.042
TTM1.765YOY1.961-0.196
TTM1.7655Y2.085-0.320
5Y2.08510Y2.186-0.101
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7221.428+0.294
TTM1.7651.433+0.332
YOY1.9611.431+0.530
5Y2.0851.440+0.645
10Y2.1861.382+0.804

1.3. Liquidity of Tela Bio Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Tela Bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 4.23 means the company has $4.23 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Tela Bio Inc:

  • The MRQ is 4.227. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.035. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.227TTM5.035-0.808
TTM5.035YOY4.455+0.581
TTM5.0355Y8.025-2.990
5Y8.02510Y7.516+0.508
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2272.787+1.440
TTM5.0352.763+2.272
YOY4.4553.488+0.967
5Y8.0253.617+4.408
10Y7.5163.537+3.979
1.3.2. Quick Ratio

Measures if Tela Bio Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tela Bio Inc to the Medical Devices industry mean.
  • A Quick Ratio of 3.33 means the company can pay off $3.33 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tela Bio Inc:

  • The MRQ is 3.328. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.953. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.328TTM3.953-0.625
TTM3.953YOY3.417+0.536
TTM3.9535Y7.020-3.067
5Y7.02010Y6.476+0.544
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3281.539+1.789
TTM3.9531.656+2.297
YOY3.4172.113+1.304
5Y7.0202.289+4.731
10Y6.4762.256+4.220

1.4. Solvency of Tela Bio Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Tela Bio Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tela Bio Inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.76 means that Tela Bio Inc assets are financed with 75.8% credit (debt) and the remaining percentage (100% - 75.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tela Bio Inc:

  • The MRQ is 0.758. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.733. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.758TTM0.733+0.025
TTM0.733YOY0.836-0.104
TTM0.7335Y1.079-0.347
5Y1.07910Y1.325-0.246
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7580.389+0.369
TTM0.7330.386+0.347
YOY0.8360.347+0.489
5Y1.0790.442+0.637
10Y1.3250.460+0.865
1.4.2. Debt to Equity Ratio

Measures if Tela Bio Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tela Bio Inc to the Medical Devices industry mean.
  • A Debt to Equity ratio of 313.4% means that company has $3.13 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tela Bio Inc:

  • The MRQ is 3.134. The company is unable to pay all its debts with equity. -1
  • The TTM is 6.017. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.134TTM6.017-2.883
TTM6.017YOY2.668+3.349
TTM6.0175Y2.244+3.773
5Y2.24410Y2.040+0.204
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1340.559+2.575
TTM6.0170.560+5.457
YOY2.6680.478+2.190
5Y2.2440.624+1.620
10Y2.0400.674+1.366

2. Market Valuation of Tela Bio Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Tela Bio Inc generates.

  • Above 15 is considered overpriced but always compare Tela Bio Inc to the Medical Devices industry mean.
  • A PE ratio of -3.16 means the investor is paying $-3.16 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tela Bio Inc:

  • The EOD is -2.247. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.165. Based on the earnings, the company is expensive. -2
  • The TTM is -4.725. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.247MRQ-3.165+0.918
MRQ-3.165TTM-4.725+1.560
TTM-4.725YOY-5.498+0.772
TTM-4.7255Y-6.958+2.233
5Y-6.95810Y-6.325-0.633
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.247-1.067-1.180
MRQ-3.165-1.578-1.587
TTM-4.725-2.341-2.384
YOY-5.498-2.969-2.529
5Y-6.958-2.081-4.877
10Y-6.325-1.463-4.862
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tela Bio Inc:

  • The EOD is -2.573. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.624. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.410. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.573MRQ-3.624+1.051
MRQ-3.624TTM-5.410+1.786
TTM-5.410YOY-5.699+0.289
TTM-5.4105Y-8.164+2.753
5Y-8.16410Y-7.421-0.742
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.573-1.015-1.558
MRQ-3.624-1.544-2.080
TTM-5.410-2.914-2.496
YOY-5.699-6.192+0.493
5Y-8.164-4.771-3.393
10Y-7.421-5.214-2.207
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Tela Bio Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 8.64 means the investor is paying $8.64 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Tela Bio Inc:

  • The EOD is 6.136. Based on the equity, the company is overpriced. -1
  • The MRQ is 8.643. Based on the equity, the company is overpriced. -1
  • The TTM is 26.210. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD6.136MRQ8.643-2.507
MRQ8.643TTM26.210-17.567
TTM26.210YOY-13.667+39.877
TTM26.2105Y6.814+19.396
5Y6.81410Y6.195+0.619
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD6.1362.021+4.115
MRQ8.6432.379+6.264
TTM26.2102.465+23.745
YOY-13.6673.219-16.886
5Y6.8143.798+3.016
10Y6.1954.163+2.032
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Tela Bio Inc.

3.1. Institutions holding Tela Bio Inc

Institutions are holding 87.054% of the shares of Tela Bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Essex Woodlands Health Ventures16.67666.7343411070900
2023-12-31Orbimed Advisors, LLC11.50340.3749283554200
2023-12-31First Light Asset Management, LLC10.36381.36062554641743772.9988
2023-12-31Nantahala Capital Management, LLC8.90780.434821957321739640381.423
2023-12-31AIGH Capital Management, LLC5.59013.608813779451250009.9765
2023-12-31BlackRock Inc4.37350.00021078056580185.6878
2023-12-31Vanguard Group Inc4.05220.0001998853228502.3412
2023-12-31Pentwater Capital Management LP4.01630.0735990000650007.027
2023-12-31SILVERARC CAPITAL MANAGEMENT, LLC3.22551.566779508030460962.1054
2023-12-31Federated Hermes Inc2.88970.011771230000
2023-12-31UBS Group AG2.79490.00146889226779336169.1965
2023-12-31Paradigm Capital Management, Inc.2.02230.1717498500279000127.1071
2023-12-31Kennedy Capital Management Inc1.55060.0553382214-5409-1.3954
2023-12-31Geode Capital Management, LLC1.40640.0002346662115173.4364
2023-12-31Worth Venture Partners, LLC1.4011.2355345331311119.901
2023-12-31State Street Corporation1.30040.00013205434167114.9427
2023-12-31Stonepine Capital Management Llc1.28920.9098317782-174137-35.3995
2023-12-31Perkins Capital Management Inc0.8531.1892102501975010.3675
2023-09-30Jacob Asset Mgmt Of NY LLC0.64821.802515977540002.5678
2023-12-31Northern Trust Corp0.5480.0002135092-1743-1.2738
Total 85.412919.531321053929+3273187+15.5%

3.2. Funds holding Tela Bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.60570.000364228300
2023-12-31Federated Hermes Kaufmann Growth2.02840.067950000000
2023-12-31Federated Hermes Kaufmann R2.02840.067950000000
2024-03-28iShares Russell 2000 ETF1.53960.00333795021830.0482
2023-12-31Kennedy Micro Cap1.2140.4179299235-4938-1.6234
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.92010.001522679900
2023-12-31Federated Hermes Kaufmann Small Cap A0.81140.031520000000
2023-12-31Federated Hermes Kaufmann Small Cap Grow0.81140.031520000000
2024-01-31Fidelity Small Cap Index0.66340.004616351441112.579
2024-03-31Paradigm Micro-Cap0.6360.53871567651676511.975
2024-01-31Calamos Timpani Small Cap Growth I0.57170.38191409252730824.0351
2023-12-31Jacob Discovery Fd Instl0.5674.57471397751800014.7814
2024-03-28iShares Russell 2000 Growth ETF0.55150.0066135938-158-0.1161
2023-12-31Timpani Small Cap Growth Equity0.46090.2881113617-59688-34.441
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.38450.00159477526002.8207
2024-02-29Fidelity Extended Market Index0.35360.001587172-422-0.4818
2023-12-31Kennedy Micro Cap Opportunities0.33151.051381723-1727-2.0695
2023-12-31Bridgeway Ultra-Small Company Market0.31240.2743770002500048.0769
2024-02-29Vanguard Russell 2000 ETF0.24030.00425923146288.4757
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.23730.00345850000
Total 17.26917.75264256754+31662+0.7%

3.3. Insider Transactions

Insiders are holding 2.656% of the shares of Tela Bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-05Gregory A FirestoneBUY26005.65
2023-11-14Antony KoblishBUY110004.54
2023-11-14Roberto CucaBUY100004.49
2023-04-21Orbimed Advisors LlcSELL277009.41
2023-04-19Orbimed Advisors LlcSELL1360009.3

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Tela Bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.4730.046-1120%-0.059-88%0.318-249%0.035-1460%
Book Value Per Share--0.7660.939-18%0.468+64%0.619+24%0.284+170%
Current Ratio--4.2275.035-16%4.455-5%8.025-47%7.516-44%
Debt To Asset Ratio--0.7580.733+3%0.836-9%1.079-30%1.325-43%
Debt To Equity Ratio--3.1346.017-48%2.668+17%2.244+40%2.040+54%
Dividend Per Share----0%0.001-100%0.000-100%0.000-100%
Eps---0.523-0.473-9%-0.449-14%-0.369-29%-0.354-32%
Free Cash Flow Per Share---0.457-0.421-8%-0.432-5%-0.341-25%-0.329-28%
Free Cash Flow To Equity Per Share---0.4560.049-1036%-0.018-96%0.060-858%0.077-693%
Gross Profit Margin--2.3322.241+4%1.936+20%1.925+21%1.924+21%
Intrinsic Value_10Y_max---22.796--------
Intrinsic Value_10Y_min---19.488--------
Intrinsic Value_1Y_max---1.665--------
Intrinsic Value_1Y_min---1.635--------
Intrinsic Value_3Y_max---5.474--------
Intrinsic Value_3Y_min---5.216--------
Intrinsic Value_5Y_max---9.853--------
Intrinsic Value_5Y_min---9.104--------
Market Cap115853120.000-41%163180352.000218087336.000-25%238238384.000-32%242589038.400-33%220535489.455-26%
Net Profit Margin---0.758-0.853+12%-1.159+53%-1.252+65%-1.334+76%
Operating Margin---0.722-0.765+6%-0.961+33%-1.092+51%-1.191+65%
Operating Ratio--1.7221.765-2%1.961-12%2.085-17%2.186-21%
Pb Ratio6.136-41%8.64326.210-67%-13.667+258%6.814+27%6.195+40%
Pe Ratio-2.247+29%-3.165-4.725+49%-5.498+74%-6.958+120%-6.325+100%
Price Per Share4.700-41%6.6208.848-25%9.665-32%9.842-33%8.947-26%
Price To Free Cash Flow Ratio-2.573+29%-3.624-5.410+49%-5.699+57%-8.164+125%-7.421+105%
Price To Total Gains Ratio-9.927+29%-13.982-12.890-8%-16.628+19%-26.016+86%-26.016+86%
Quick Ratio--3.3283.953-16%3.417-3%7.020-53%6.476-49%
Return On Assets---0.165-0.161-3%-0.192+16%-0.147-11%-0.151-9%
Return On Equity---0.683-1.446+112%-0.595-13%-0.511-25%-0.465-32%
Total Gains Per Share---0.4730.046-1120%-0.058-88%0.318-249%0.035-1452%
Usd Book Value--18881000.00023144750.000-18%11525500.000+64%15265700.000+24%6988363.636+170%
Usd Book Value Change Per Share---0.4730.046-1120%-0.059-88%0.318-249%0.035-1460%
Usd Book Value Per Share--0.7660.939-18%0.468+64%0.619+24%0.284+170%
Usd Dividend Per Share----0%0.001-100%0.000-100%0.000-100%
Usd Eps---0.523-0.473-9%-0.449-14%-0.369-29%-0.354-32%
Usd Free Cash Flow---11256000.000-10367000.000-8%-10655000.000-5%-8399500.000-25%-8118090.909-28%
Usd Free Cash Flow Per Share---0.457-0.421-8%-0.432-5%-0.341-25%-0.329-28%
Usd Free Cash Flow To Equity Per Share---0.4560.049-1036%-0.018-96%0.060-858%0.077-693%
Usd Market Cap115853120.000-41%163180352.000218087336.000-25%238238384.000-32%242589038.400-33%220535489.455-26%
Usd Price Per Share4.700-41%6.6208.848-25%9.665-32%9.842-33%8.947-26%
Usd Profit---12890000.000-12170750.000-6%-11735250.000-9%-9005950.000-30%-8650727.273-33%
Usd Revenue--16998000.00014613250.000+16%10354500.000+64%8149650.000+109%7619636.364+123%
Usd Total Gains Per Share---0.4730.046-1120%-0.058-88%0.318-249%0.035-1452%
 EOD+3 -5MRQTTM+9 -25YOY+12 -245Y+11 -2510Y+11 -25

4.2. Fundamental Score

Let's check the fundamental score of Tela Bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.247
Price to Book Ratio (EOD)Between0-16.136
Net Profit Margin (MRQ)Greater than0-0.758
Operating Margin (MRQ)Greater than0-0.722
Quick Ratio (MRQ)Greater than13.328
Current Ratio (MRQ)Greater than14.227
Debt to Asset Ratio (MRQ)Less than10.758
Debt to Equity Ratio (MRQ)Less than13.134
Return on Equity (MRQ)Greater than0.15-0.683
Return on Assets (MRQ)Greater than0.05-0.165
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Tela Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.315
Ma 20Greater thanMa 505.272
Ma 50Greater thanMa 1006.094
Ma 100Greater thanMa 2006.141
OpenGreater thanClose5.000
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets78,048
Total Liabilities59,167
Total Stockholder Equity18,881
 As reported
Total Liabilities 59,167
Total Stockholder Equity+ 18,881
Total Assets = 78,048

Assets

Total Assets78,048
Total Current Assets71,726
Long-term Assets6,322
Total Current Assets
Cash And Cash Equivalents 46,729
Net Receivables 9,737
Inventory 13,162
Other Current Assets 2,098
Total Current Assets  (as reported)71,726
Total Current Assets  (calculated)71,726
+/-0
Long-term Assets
Property Plant Equipment 3,938
Long-term Assets Other 265
Long-term Assets  (as reported)6,322
Long-term Assets  (calculated)4,203
+/- 2,119

Liabilities & Shareholders' Equity

Total Current Liabilities16,967
Long-term Liabilities42,200
Total Stockholder Equity18,881
Total Current Liabilities
Short-term Debt 565
Accounts payable 1,667
Other Current Liabilities 14,735
Total Current Liabilities  (as reported)16,967
Total Current Liabilities  (calculated)16,967
+/-0
Long-term Liabilities
Long term Debt 40,515
Long-term Liabilities Other 1,685
Long-term Liabilities  (as reported)42,200
Long-term Liabilities  (calculated)42,200
+/-0
Total Stockholder Equity
Common Stock24
Retained Earnings -320,889
Accumulated Other Comprehensive Income 91
Other Stockholders Equity 339,655
Total Stockholder Equity (as reported)18,881
Total Stockholder Equity (calculated)18,881
+/-0
Other
Capital Stock24
Cash and Short Term Investments 46,729
Common Stock Shares Outstanding 24,490
Liabilities and Stockholders Equity 78,048
Net Debt -3,949
Net Invested Capital 59,396
Net Working Capital 54,759
Property Plant and Equipment Gross 8,273
Short Long Term Debt Total 42,780



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
> Total Assets 
27,227
27,227
26,627
28,916
23,050
67,922
58,841
97,550
92,351
86,458
78,319
73,799
68,809
62,544
55,355
51,333
79,563
67,855
58,788
94,386
87,317
78,048
78,04887,31794,38658,78867,85579,56351,33355,35562,54468,80973,79978,31986,45892,35197,55058,84167,92223,05028,91626,62727,22727,227
   > Total Current Assets 
23,254
23,254
22,753
25,042
17,616
64,334
55,313
94,113
89,016
83,225
75,204
70,735
65,539
59,055
50,329
45,634
73,955
62,447
53,502
89,168
82,252
71,726
71,72682,25289,16853,50262,44773,95545,63450,32959,05565,53970,73575,20483,22589,01694,11355,31364,33417,61625,04222,75323,25423,254
       Cash And Cash Equivalents 
17,278
17,278
15,873
18,162
10,701
45,302
41,411
85,471
81,467
74,394
65,829
60,292
53,636
43,931
33,016
27,725
54,226
42,019
30,124
65,266
58,202
46,729
46,72958,20265,26630,12442,01954,22627,72533,01643,93153,63660,29265,82974,39481,46785,47141,41145,30210,70118,16215,87317,27817,278
       Short-term Investments 
0
0
0
0
0
9,285
5,289
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000005,2899,28500000
       Net Receivables 
1,298
1,298
1,897
1,897
2,278
2,836
2,047
2,586
2,640
2,683
2,795
3,545
3,573
4,234
4,311
5,306
5,688
6,621
6,654
7,894
8,072
9,737
9,7378,0727,8946,6546,6215,6885,3064,3114,2343,5733,5452,7952,6832,6402,5862,0472,8362,2781,8971,8971,2981,298
       Inventory 
4,348
4,348
4,599
4,599
4,272
4,603
4,803
4,572
4,042
3,907
4,688
4,503
6,269
7,658
10,267
10,291
12,138
11,792
15,105
14,098
14,323
13,162
13,16214,32314,09815,10511,79212,13810,29110,2677,6586,2694,5034,6883,9074,0424,5724,8034,6034,2724,5994,5994,3484,348
   > Long-term Assets 
0
3,973
0
3,874
5,434
3,588
3,528
3,437
3,335
3,233
3,115
3,064
3,270
3,489
5,026
5,699
5,608
5,408
5,286
5,218
5,065
6,322
6,3225,0655,2185,2865,4085,6085,6995,0263,4893,2703,0643,1153,2333,3353,4373,5283,5885,4343,87403,9730
       Property Plant Equipment 
758
758
712
712
716
677
693
678
652
626
584
609
891
1,186
2,799
3,010
3,014
2,909
2,882
2,909
2,851
3,938
3,9382,8512,9092,8822,9093,0143,0102,7991,186891609584626652678693677716712712758758
       Intangible Assets 
3,215
3,215
3,063
3,063
2,987
2,911
2,835
2,759
2,683
2,607
2,531
2,455
2,379
2,303
2,227
2,689
2,594
2,499
2,404
2,309
2,214
0
02,2142,3092,4042,4992,5942,6892,2272,3032,3792,4552,5312,6072,6832,7592,8352,9112,9873,0633,0633,2153,215
       Other Assets 
0
0
99
99
1,731
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000001,731999900
> Total Liabilities 
40,937
165,087
39,311
37,633
183,450
36,960
34,614
34,147
36,018
37,432
36,628
38,834
41,080
42,446
45,317
52,875
56,262
53,550
55,647
54,381
56,765
59,167
59,16756,76554,38155,64753,55056,26252,87545,31742,44641,08038,83436,62837,43236,01834,14734,61436,960183,45037,63339,311165,08740,937
   > Total Current Liabilities 
9,559
9,559
7,649
7,649
6,309
6,713
4,232
3,623
5,345
6,605
5,638
7,294
9,377
10,575
12,286
11,926
15,214
12,403
14,406
13,045
15,334
16,967
16,96715,33413,04514,40612,40315,21411,92612,28610,5759,3777,2945,6386,6055,3453,6234,2326,7136,3097,6497,6499,5599,559
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
347
336
338
340
342
343
345
565
56534534334234033833634700000000000000
       Accounts payable 
3,421
3,421
2,109
2,109
1,701
3,171
1,389
948
976
652
965
1,277
2,334
2,414
5,703
2,246
4,856
1,534
5,216
2,250
3,091
1,667
1,6673,0912,2505,2161,5344,8562,2465,7032,4142,3341,2779656529769481,3893,1711,7012,1092,1093,4213,421
       Other Current Liabilities 
985
6,138
1,007
5,540
4,608
3,542
2,843
2,675
4,369
5,953
4,673
6,017
7,043
8,161
6,236
9,344
10,020
10,529
8,848
10,795
12,243
14,735
14,73512,24310,7958,84810,52910,0209,3446,2368,1617,0436,0174,6735,9534,3692,6752,8433,5424,6085,5401,0076,138985
   > Long-term Liabilities 
0
155,528
0
29,984
177,141
30,247
30,382
30,524
30,673
30,827
30,990
31,540
31,703
31,871
33,031
40,949
41,048
41,147
41,241
41,336
41,431
42,200
42,20041,43141,33641,24141,14741,04840,94933,03131,87131,70331,54030,99030,82730,67330,52430,38230,247177,14129,9840155,5280
       Long term Debt Total 
0
0
0
31,655
31,752
30,243
30,381
0
0
0
30,982
31,145
31,315
31,491
31,669
39,617
39,766
39,916
40,063
40,212
0
0
0040,21240,06339,91639,76639,61731,66931,49131,31531,14530,98200030,38130,24331,75231,655000
       Long-term Liabilities Other 
0
0
0
7
5
4
1
0
0
0
8
395
388
380
1,362
1,332
1,282
1,231
1,178
1,124
1,068
1,685
1,6851,0681,1241,1781,2311,2821,3321,36238038839580001457000
       Deferred Long Term Liability 
0
0
99
99
1,731
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000001,731999900
> Total Stockholder Equity
-137,860
-137,860
-153,747
-8,717
-160,400
30,962
24,227
63,403
56,333
49,026
41,691
34,965
27,729
20,098
10,038
-1,542
23,301
14,305
3,141
40,005
30,552
18,881
18,88130,55240,0053,14114,30523,301-1,54210,03820,09827,72934,96541,69149,02656,33363,40324,22730,962-160,400-8,717-153,747-137,860-137,860
   Common Stock
7
7
7
8
-147,028
11
11
14
14
14
14
14
15
15
15
15
19
19
19
24
24
24
2424241919191515151514141414141111-147,0288777
   Retained Earnings -320,889-307,999-297,042-286,252-274,225-264,246-253,532-240,791-229,929-221,310-213,044-204,789-196,653-188,863-181,160-175,079-167,859-160,398-153,744-153,751-137,860-137,867
   Capital Surplus 
0
0
0
0
0
198,829
199,287
0
0
0
246,548
248,076
249,067
250,064
250,819
251,846
287,266
288,361
289,254
336,939
0
0
00336,939289,254288,361287,266251,846250,819250,064249,067248,076246,548000199,287198,82900000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
0
3,243
-3
145,022
145,384
198,829
199,287
244,537
245,199
245,736
246,548
248,076
249,067
250,064
250,819
251,846
287,266
288,361
289,254
336,939
338,392
339,655
339,655338,392336,939289,254288,361287,266251,846250,819250,064249,067248,076246,548245,736245,199244,537199,287198,829145,384145,022-33,2430



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue58,453
Cost of Revenue-18,341
Gross Profit40,11240,112
 
Operating Income (+$)
Gross Profit40,112
Operating Expense-84,187
Operating Income-44,075-44,075
 
Operating Expense (+$)
Research Development9,619
Selling General Administrative14,887
Selling And Marketing Expenses59,681
Operating Expense84,18784,187
 
Net Interest Income (+$)
Interest Income0
Interest Expense-5,223
Other Finance Cost-171
Net Interest Income-5,052
 
Pretax Income (+$)
Operating Income-44,075
Net Interest Income-5,052
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-46,664-41,486
EBIT - interestExpense = -49,298
-46,664
-41,441
Interest Expense5,223
Earnings Before Interest and Taxes (EBIT)-44,075-41,441
Earnings Before Interest and Taxes (EBITDA)-43,267
 
After tax Income (+$)
Income Before Tax-46,664
Tax Provision-0
Net Income From Continuing Ops-43,753-46,664
Net Income-46,664
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses102,528
Total Other Income/Expenses Net-2,5895,052
 

Technical Analysis of Tela Bio Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tela Bio Inc. The general trend of Tela Bio Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tela Bio Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tela Bio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5.18 < 5.24 < 6.05.

The bearish price targets are: 4.235.

Tweet this
Tela Bio Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tela Bio Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tela Bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tela Bio Inc. The current macd is -0.33080894.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tela Bio Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Tela Bio Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Tela Bio Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Tela Bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartTela Bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tela Bio Inc. The current adx is 29.79.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Tela Bio Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Tela Bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tela Bio Inc. The current sar is 5.38461012.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Tela Bio Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tela Bio Inc. The current rsi is 29.32. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Tela Bio Inc Daily Relative Strength Index (RSI) ChartTela Bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tela Bio Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tela Bio Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Tela Bio Inc Daily Stochastic Oscillator ChartTela Bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tela Bio Inc. The current cci is -148.53838385.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Tela Bio Inc Daily Commodity Channel Index (CCI) ChartTela Bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tela Bio Inc. The current cmo is -51.09663588.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Tela Bio Inc Daily Chande Momentum Oscillator (CMO) ChartTela Bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tela Bio Inc. The current willr is -94.73684211.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Tela Bio Inc Daily Williams %R ChartTela Bio Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tela Bio Inc.

Tela Bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tela Bio Inc. The current atr is 0.29218248.

Tela Bio Inc Daily Average True Range (ATR) ChartTela Bio Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tela Bio Inc. The current obv is -5,720,737.

Tela Bio Inc Daily On-Balance Volume (OBV) ChartTela Bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tela Bio Inc. The current mfi is 28.66.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Tela Bio Inc Daily Money Flow Index (MFI) ChartTela Bio Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tela Bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

Tela Bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tela Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.315
Ma 20Greater thanMa 505.272
Ma 50Greater thanMa 1006.094
Ma 100Greater thanMa 2006.141
OpenGreater thanClose5.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Tela Bio Inc with someone you think should read this too:
  • Are you bullish or bearish on Tela Bio Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tela Bio Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tela Bio Inc

I send you an email if I find something interesting about Tela Bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Tela Bio Inc.

Receive notifications about Tela Bio Inc in your mailbox!